GE HealthCare Technologies (NASDAQ:GEHC) Announces Quarterly Earnings Results, Beats Expectations By $0.19 EPS

GE HealthCare Technologies (NASDAQ:GEHC) issued its quarterly earnings data on Thursday. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19, Zacks reports. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies updated its FY 2025 guidance to 4.610-4.750 EPS.

GE HealthCare Technologies Trading Up 8.8 %

Shares of NASDAQ GEHC opened at $93.48 on Friday. GE HealthCare Technologies has a one year low of $74.51 and a one year high of $94.80. The firm has a market capitalization of $42.71 billion, a PE ratio of 25.68, a PEG ratio of 2.93 and a beta of 1.15. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The business has a 50-day moving average price of $83.81 and a two-hundred day moving average price of $85.44.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. The ex-dividend date is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.85%.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Citigroup boosted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Wells Fargo & Company boosted their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $97.31.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.